Abstract
CLL-403 Real-World Dosing Patterns and Time to Next Treatment for Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With or Without Ibrutinib Dose Reduction Following an Adverse Event
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have